Skip to content

Femoral Triangle Block vs Adductor Canal Block on Early Quadriceps Function After Total Knee Arthroplasty

Postoperative Effects of Femoral Triangle Block Versus Adductor Canal Block on Early Quadriceps Function After Total Knee Arthroplasty Under a Multimodal Analgesia Protocol: A Randomized Double-Blind Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07524387
Enrollment
136
Registered
2026-04-13
Start date
2026-04-13
Completion date
2029-03-31
Last updated
2026-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Arthroplasty, Total Knee Arthroplasty Postoperative Pain, Total Knee Arthroplasty Recovery

Keywords

Postoperative Pain, Total Knee Arthroplasty, Peripheral Nerve Block, Postoperative Recovery

Brief summary

The goal of this clinical trial is to compare the effects of femoral triangle block (FTB) and adductor canal block (ACB) on early quadriceps function after total knee arthroplasty (TKA). The main question it aims to answer is whether FTB causes more early quadriceps functional impairment than ACB under a standardized multimodal analgesia protocol. Researchers will compare FTB and ACB using a composite binary functional outcome measured 6 hours after block completion. Quadriceps functional impairment is defined as the inability to perform a structured straight leg raise or quadriceps muscle strength \<50% of the preoperative baseline. Participants will be randomly assigned to receive ultrasound-guided FTB or ACB. All participants will also receive a popliteal plexus block and standardized multimodal analgesia.

Detailed description

This is a single-center, randomized, parallel-group clinical trial designed to compare the postoperative effects of femoral triangle block (FTB) and adductor canal block (ACB) on early quadriceps function after primary unilateral total knee arthroplasty (TKA). A total of 136 adult participants are planned for enrollment at Daiyukai General Hospital. Participants will be randomly assigned to receive ultrasound-guided FTB or ultrasound-guided ACB as part of a standardized multimodal analgesia protocol. In all participants, a popliteal plexus block will also be performed to standardize posterior knee analgesia. The primary outcome is quadriceps functional impairment at 6 hours after block completion, assessed using a composite binary functional outcome defined as the inability to perform a structured straight leg raise or normalized isometric quadriceps muscle strength \<50% of the preoperative baseline. Secondary outcomes include quadriceps functional impairment at 24 hours after block completion using the same composite definition, postoperative pain intensity, rescue analgesic consumption, early mobilization and rehabilitation-related measures, active knee range of motion, time to achieve active knee flexion of at least 120 degrees, and ultrasound-assessed local anesthetic spread. The study aims to determine whether FTB results in greater early motor impairment than ACB under a standardized multimodal analgesia protocol while maintaining clinically appropriate postoperative analgesia.

Interventions

PROCEDUREFemoral Triangle Block (FTB) Group

Ultrasound-guided femoral triangle block performed as part of a standardized multimodal analgesia protocol for total knee arthroplasty. A total of 10 mL of 0.25% levobupivacaine is injected in the femoral triangle to achieve sensory blockade of the saphenous nerve, the nerve to vastus medialis, and surrounding structures. The injection is performed at the distal femoral triangle under ultrasound guidance, targeting the perineural space adjacent to the relevant nerve branches. In all participants, a popliteal plexus block using 15 mL of 0.25% levobupivacaine is additionally performed to standardize posterior knee analgesia.

Ultrasound-guided adductor canal block performed as part of a standardized multimodal analgesia protocol for total knee arthroplasty. A total of 10 mL of 0.25% levobupivacaine is administered in a divided manner within the proximal adductor canal, targeting both the saphenous nerve within the canal and the nerve to vastus medialis running adjacent to the canal. The injection is performed under ultrasound guidance to achieve selective sensory blockade while minimizing motor involvement. In all participants, a popliteal plexus block using 15 mL of 0.25% levobupivacaine is additionally performed to standardize posterior knee analgesia.

Sponsors

Social Medical Corporation Daiyukai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Randomized, double-blind, parallel-group trial with two intervention arms (FTB and ACB).

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult patients (≥ 20 years of age) are scheduled to undergo primary unilateral TKA. 2. American Society of Anesthesiologists (ASA) physical status I-III. 3. Ability to ambulate independently prior to surgery. 4. Ability to understand the study procedures and provide written informed consent. 5. Planned perioperative anesthesia management including regional anesthesia as part of standard clinical care. 6. Ability to extend the knee below 30 degrees preoperatively (no knee extension contracture)

Exclusion criteria

1. Known allergy or contraindication to local anesthetic agents used in this study. 2. Pre-existing neurological or neuromuscular disorders affect lower limb strength or motor control. 3. Severe cognitive impairment or psychiatric conditions interfere with study participation or assessment. 4. History of revision knee arthroplasty on the operative side. 5. Severe preoperative quadriceps weakness that precludes reliable baseline strength assessment. 6. Any condition deemed by the investigator to make participation inappropriate.

Design outcomes

Primary

MeasureTime frameDescription
Participants with quadriceps functional impairment at 6 hours after block completion6 hours after block completionComposite binary functional outcome defined as the inability to perform a structured straight leg raise (SLR) or normalized isometric quadriceps muscle strength \<50% of the preoperative baseline. The outcome will be reported as the percentage of participants with quadriceps functional impairment.

Secondary

MeasureTime frameDescription
Participants with quadriceps functional impairment at 24 hours after block completion24 hours after block completionComposite binary functional outcome defined as the inability to perform a structured SLR or normalized isometric quadriceps muscle strength \<50% of the preoperative baseline. The outcome will be reported as the percentage of participants with quadriceps functional impairment.
Participants able to perform a structured straight leg raise at 6 and 24 hours after block completion6 and 24 hours after block completionAbility to perform a structured straight leg raise (SLR), assessed using the predefined study procedure. The outcome will be reported as the percentage of participants able to perform the structured SLR.
Normalized isometric quadriceps muscle strength at 6 and 24 hours after block completion6 and 24 hours after block completionNormalized isometric quadriceps muscle strength, expressed as a percentage of the preoperative baseline (%MVIC). Higher values indicate greater preservation of quadriceps strength.
Postoperative pain intensity at rest on the Numeric Rating Scale1, 2, 3, 6, 12, 18, and 24 hours after surgeryPain intensity at rest assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable; higher scores indicate worse pain. Pain will be assessed postoperatively after patient awakening.
Postoperative pain intensity during active knee movement on the Numeric Rating Scale1, 2, 3, 6, 12, 18, and 24 hours after surgeryPain intensity during active knee movement assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable; higher scores indicate worse pain. Pain will be assessed postoperatively after patient awakening.
Participants requiring any rescue analgesic during the first 24 postoperative hoursWithin the first postoperative 24 hoursProportion of participants who receive at least one rescue analgesic during the first 24 postoperative hours. Rescue analgesia is permitted when the Numeric Rating Scale (NRS) pain score is 5 or higher or when the participant requests additional analgesia. Allowed rescue analgesics include loxoprofen, acetaminophen, diclofenac suppository, and intramuscular pentazocine. The choice of rescue agent is left to the treating clinical team, and no fixed sequence of rescue analgesics is mandated.
Number of rescue analgesic administrations during the first 48 postoperative hoursWithin the first postoperative 48 hoursTotal number of rescue analgesic administrations per participant during the first 48 postoperative hours. Rescue analgesia is permitted when the Numeric Rating Scale (NRS) pain score is 5 or higher or when the participant requests additional analgesia. Allowed rescue analgesics include loxoprofen, acetaminophen, diclofenac suppository, and intramuscular pentazocine. The choice of rescue agent is left to the treating clinical team, and no fixed sequence of rescue analgesics is mandated.
Time to first mobilizationWithin 24 hours after block completionTime from block completion to the first documented mobilization attempt.
Ability to stand during the first postoperative rehabilitation sessionPostoperative day 1Proportion of participants able to complete supported standing during the first routine postoperative rehabilitation session, as assessed and documented by a physical therapist.
Walking distance during routine postoperative rehabilitationFrom postoperative days 1 to 7Distance ambulated in meters during supervised postoperative rehabilitation sessions, as assessed and documented by a physical therapist.
Active knee flexion angle of the operated kneePostoperative days 1, 2, 3, and 7Active knee flexion angle of the operated knee, measured in degrees by rehabilitation staff using a goniometer during routine postoperative rehabilitation assessment. Higher values indicate greater knee flexion.
Active knee extension deficit angle of the operated kneePostoperative days 1, 2, 3, and 7Active knee extension deficit angle of the operated knee, measured in degrees by rehabilitation staff using a goniometer during routine postoperative rehabilitation assessment, where 0 degrees indicates full knee extension and higher values indicate greater residual extension limitation.
Time to achieve active knee flexion of at least 120 degreesUp to postoperative day 7Number of days required to achieve active knee flexion of the operated knee of at least 120 degrees, based on routine postoperative rehabilitation assessment by rehabilitation staff using a goniometer.
Cranial spread of local anesthetic from the injection pointImmediately after block completionCranial spread of local anesthetic from the injection point, measured in centimeters on ultrasound immediately after block completion. Higher values indicate greater cranial spread of the injectate.
Caudal spread of local anesthetic from the injection pointImmediately after block completionCaudal spread of local anesthetic from the injection point, measured in centimeters on ultrasound immediately after block completion. Higher values indicate greater caudal spread of the injectate.

Countries

Japan

Contacts

CONTACTNorihiro Sakai, MD, PhD
dykmasui@gmail.com+81-586-72-1211
CONTACTTomohiro Michino, MD, PhD
dykmasui@gmail.com+81-586-72-1211
PRINCIPAL_INVESTIGATORNorihiro Sakai, MD, PhD

Department of Anesthesiology, Daiyukai General Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 17, 2026